NCT01147549View on ClinicalTrials.gov

Single Oral Dose of 60 mg [14C]AZD9668 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Healthy

Interventions

DRUG

[C14]AZD9668

Oral Solution 60 mg Single Dose

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY